Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Sherman

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Behavior Genetics|June 23, 2005
Examination of the effect of the polymorphic CGG repeat in the FMR1 gene on cognitive performanceEmily Graves Allen, Stephanie Sherman, Ann Abramowitz, et al.
Human Mutation|March 24, 2009
Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome-Hirschsprung disease associationStacey Arnold, Anna Pelet, Jeanne Amiel, et al.
Journal of Neurodevelopmental Disorders|August 20, 2014
The cognitive neuropsychological phenotype of carriers of the FMR1 premutationJim Grigsby, Kim Cornish, Darren Hocking, et al.
Brain Sciences|October 23, 2021
Symptoms of Autism Spectrum Disorder in Individuals with Down SyndromeAmanda Dimachkie Nunnally, Vivian Nguyen, Claudine Anglo, et al.
Journal of Neurodevelopmental Disorders|April 4, 2020
Correction to: Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validityLeonard Abbeduto, Elizabeth Berry-Kravis, Audra Sterling, et al.
Journal of Neurodevelopmental Disorders|March 25, 2020
Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validityLeonard Abbeduto, Elizabeth Berry-Kravis, Audra Sterling, et al.
American Journal of Human Genetics|August 2, 2007
Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalancePaola Prandini, Samuel Deutsch, Robert Lyle, et al.
Nature Genetics|October 7, 2004
Recombination rate and reproductive success in humansAugustine Kong, John Barnard, Daniel F Gudbjartsson, et al.
Molecular Syndromology|April 17, 2023
Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research SocietyEric D Hamlett, Lisi Flores-Aguilar, Benjamin Handen, et al.
Journal of Genetic Counseling|May 15, 2007
Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disordersAllyn McConkie-Rosell, Liane Abrams, Brenda Finucane, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Behavior Genetics|June 23, 2005
Examination of the effect of the polymorphic CGG repeat in the FMR1 gene on cognitive performanceEmily Graves Allen, Stephanie Sherman, Ann Abramowitz, et al.
Human Mutation|March 24, 2009
Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome-Hirschsprung disease associationStacey Arnold, Anna Pelet, Jeanne Amiel, et al.
Journal of Neurodevelopmental Disorders|August 20, 2014
The cognitive neuropsychological phenotype of carriers of the FMR1 premutationJim Grigsby, Kim Cornish, Darren Hocking, et al.
Brain Sciences|October 23, 2021
Symptoms of Autism Spectrum Disorder in Individuals with Down SyndromeAmanda Dimachkie Nunnally, Vivian Nguyen, Claudine Anglo, et al.
Journal of Neurodevelopmental Disorders|April 4, 2020
Correction to: Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validityLeonard Abbeduto, Elizabeth Berry-Kravis, Audra Sterling, et al.
Journal of Neurodevelopmental Disorders|March 25, 2020
Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validityLeonard Abbeduto, Elizabeth Berry-Kravis, Audra Sterling, et al.
American Journal of Human Genetics|August 2, 2007
Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalancePaola Prandini, Samuel Deutsch, Robert Lyle, et al.
Nature Genetics|October 7, 2004
Recombination rate and reproductive success in humansAugustine Kong, John Barnard, Daniel F Gudbjartsson, et al.
Molecular Syndromology|April 17, 2023
Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research SocietyEric D Hamlett, Lisi Flores-Aguilar, Benjamin Handen, et al.
Journal of Genetic Counseling|May 15, 2007
Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disordersAllyn McConkie-Rosell, Liane Abrams, Brenda Finucane, et al.
Pageof 4